Live from the NIH registry
Studies recruiting near Flint right now
Top 25 of 172 recruiting studies, sorted by proximity — each links to its official registry page
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Ahmed Arif Medical Research Center — Grand Blanc, Michigan (7.3 mi)
· Sponsor: Novartis Pharmaceuticals
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Genesys Hurley Cancer Institute — Flint, Michigan (0.8 mi)
· Sponsor: NRG Oncology
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Elite Research Center — Flint, Michigan (0.8 mi)
· Sponsor: Novo Nordisk A/S
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Wright & Filippis x Ottobock.care — Flint, Michigan (0.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Intracranial Aneurysm
N/A
Observational 118 participants sought
McLaren Healthcare — Flint, Michigan (0.8 mi)
· Sponsor: Medtronic Neurovascular Clinical Affairs
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
McLaren Proton Therapy Center — Flint, Michigan (0.8 mi)
· Sponsor: Proton Collaborative Group
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
Pancreatic Cancer
Phase 2
Interventional 60 participants sought
McLaren Proton Therapy Center — Flint, Michigan (0.8 mi)
· Sponsor: Proton Collaborative Group
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Elite Research Center — Flint, Michigan (0.8 mi)
· Sponsor: Zucara Therapeutics Inc.
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi)
· Sponsor: NRG Oncology
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma Recurrent
N/A
Interventional 198 participants sought
Karmanos Cancer Institute at McLaren Flint — Flint, Michigan (0.8 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Michigan Dermatology Institute - Waterford- Site Number : 8400013 — Waterford, Michigan (26.9 mi)
· Sponsor: Sanofi
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Genesys Hurley Cancer Institute — Flint, Michigan (0.8 mi)
· Sponsor: American Society of Clinical Oncology
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma
Phase 2
Interventional 227 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: SWOG Cancer Research Network
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 1,196 participants sought
GSK Investigational Site — Clarkston, Michigan (24.2 mi)
· Sponsor: GlaxoSmithKline
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Flint, Michigan (0.8 mi)
· Sponsor: GlaxoSmithKline
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Phase 2
Interventional 46 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Ask Questions About Clinical Trials
Oncology, Cardiac Disease
N/A
Interventional 293 participants sought
Karmanos Cancer Institute at McLaren Lapeer — Lapeer, Michigan (18.9 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Ahmed Arif Medical Research Center — Grand Blanc, Michigan (7.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Retina Associates of Michigan — Grand Blanc, Michigan (7.3 mi)
· Sponsor: Astellas Pharma Global Development, Inc.